Generics and biosimilars in Italy

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about generics and biosimilars market in Italy

Nowadays, generic and biosimilar drugs are considered the key for cutting pharmaceutical expenditure. Apart from the saving expenses aspect, generics and biosimilars are different kind of products. In fact, generics are duplicates of brand-name drugs which do not have a registered trademark. Biosimilars, on the other hand, are drugs of biological origin which are very similar in function and effect to previously approved biological products. After providing a global overview of the market of generics and biosimilars, this dossier offers some insights about the Italian market.

Table of contents

  • 1. Global overview
    • Pharmaceutical sales worldwide 2007-2018

    • Total worldwide generic prescription drug revenue 2010-2024

    • Global generic prescription drug revenues as share of prescribed revenue 2010-2024

    • Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020

    • Country-wise biosimilar pipelines number in development worldwide 2017

  • 2. Italy: pharmaceutical market and industry
    • Italy: pharmacy turnover 2018, by segment

    • Italy: pharmacy sales volume 2018, by segment

    • Industry revenue of »manufacture of pharmaceutical preparations« in Italy 2011-2023

    • Industry revenue of »manufacture of basic pharmaceutical products« in Italy 2011-2023

    • Industry revenue of »wholesale of pharmaceutical goods« in Italy 2011-2023

    • Investments in R&D in the pharmaceutical sector in Italy 2012-2018

  • 3. Biosimilar drugs
    • Italy: estimated market value of biosimilars 2018-2022, by type

    • Italy: market share of biosimilars 2017, by molecule

    • Share of consumption of biosimilar drugs in Italy 2016-2018

    • Consumption volume of biosimilar drugs in Italy 2016-2018

    • Incidence of biosimilars on the total marketed products in Italy in 2018, by molecule

    • Share of biosimilar drugs consumed in Italy 2018, by region

    • Italy: average prices of biosimilars and originators 2016-2017

  • 4. Generic drugs
    • Share value of the generic pharmaceuticals market in Italy 2006-2018

    • Volume share of the generic pharmaceuticals market in Italy 2006-2018

    • Generic market share in community and hospital pharmacies in Italy 2004-2018

    • Italy: incidence of generics on total drugs consumption 2018, by region

    • Italy: incidence of generics on public pharmaceutical expenditure 2018, by region

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!